EXAS
Exact Sciences Corp
Price:  
57.51 
USD
Volume:  
1,907,071.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EXAS EV/EBITDA

-106.0%
Upside

As of 2024-02-27, the EV/EBITDA ratio of Exact Sciences Corp (EXAS) is 384.28. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EXAS's latest enterprise value is 12,181.68 mil USD. EXAS's TTM EBITDA according to its financial statements is 31.70 mil USD. Dividing these 2 quantities gives us the above EXAS EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative Enterprise Value.

Range Selected
Trailing P/E multiples 21.4x - 31.4x 29.7x
Forward P/E multiples 34.2x - 43.3x 43.2x
Fair Price (6.09) - (2.25) (3.46)
Upside -110.6% - -103.9% -106.0%
57.51 USD
Stock Price
(3.46) USD
Fair Price

EXAS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-02-26 384.28
2024-02-23 384.39
2024-02-22 395.58
2024-02-21 417.26
2024-02-20 414.12
2024-02-16 404.02
2024-02-15 404.70
2024-02-14 410.41
2024-02-13 395.35
2024-02-12 410.41
2024-02-09 402.14
2024-02-08 404.08
2024-02-07 404.99
2024-02-06 424.73
2024-02-05 412.41
2024-02-02 421.59
2024-02-01 420.91
2024-01-31 429.29
2024-01-30 430.89
2024-01-29 437.62
2024-01-26 422.90
2024-01-25 422.79
2024-01-24 422.56
2024-01-23 430.78
2024-01-22 432.77
2024-01-19 431.86
2024-01-18 428.15
2024-01-17 421.71
2024-01-16 432.77
2024-01-12 439.11
2024-01-11 447.78
2024-01-10 456.16
2024-01-09 453.14
2024-01-08 458.79
2024-01-05 473.79
2024-01-04 462.55
2024-01-03 455.19
2024-01-02 477.04
2023-12-29 478.24
2023-12-28 488.17
2023-12-27 487.94
2023-12-26 487.77
2023-12-22 475.56
2023-12-21 463.69
2023-12-20 440.13
2023-12-19 452.28
2023-12-18 424.73
2023-12-15 432.15
2023-12-14 442.99
2023-12-13 442.47